RxDoctor Payments Data

Amy Harrell

Family · Jefferson City, MONPI 1811338767

Payments from drug & device makers

$5,439in general payments, 2019–2025

Across 378 payments — averaging $14.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$554
  • Pfizer$366
  • Lilly USA, LLC$353
  • AstraZeneca$292
  • Astellas Pharma US Inc$224
  • plus $2K from 40 others

What the payments were for

  • Food & beverage$5,37499%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,439 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$34,235
Medicare patients
170
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$38,920
FarxigaDapagliflozin Propanediol46$34,718
OzempicSemaglutide22$20,168
MyrbetriqMirabegron35$19,617
TrulicityDulaglutide17$17,876
LinzessLinaclotide19$15,712
Spiriva RespimatTiotropium Bromide24$12,017
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,256
Repatha SureclickEvolocumab13$11,064
Bydureon BciseExenatide Microspheres13$9,866
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$9,482
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$8,552
VerquvoVericiguat13$8,294
DuleraMometasone/Formoterol20$8,133
AbrysvoRsv Vacc, Pref A And Pref B/Pf21$6,434

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$292$45,97465 claims
PfizerEliquis, Abrysvo$366$45,35483 claims
Novo NordiskOzempic$554$20,16822 claims
Astellas Pharma US IncMyrbetriq$224$19,61735 claims
Lilly USA, LLCTrulicity$353$17,87617 claims
MerckVerquvo, Dulera$127$16,42833 claims
AbbVieLinzess$1,401$15,71219 claims
Boehringer IngelheimSpiriva Respimat$224$12,01724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.

Other family in Jefferson City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →